about
The Protective Role of HLA-DRB1(∗)13 in Autoimmune Diseases.Age of onset of mesial temporal lobe epilepsy with hippocampal sclerosis: the effect of apolipoprotein E and febrile seizures.The vitamin D receptor gene FokI polymorphism and Multiple Sclerosis in a Northern Portuguese population.Characteristics of Neuro-Behçet's Disease in a Case-Series from a Single Centre in Northern Portugal.Cognitive reserve in multiple sclerosis: Protective effects of education.Cognitive functioning in Behçet's disease.Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis.Immunogenetic predisposing factors for mesial temporal lobe epilepsy with hippocampal sclerosis.Olfactory dysfunction in multiple sclerosis: association with secondary progression.Serum 25-hydroxyvitamin D levels in a healthy population from the North of Portugal.Serum 25-hydroxyvitamin D levels in multiple sclerosis patients from the north of Portugal.Crosstalk between inflammation, iron metabolism and endothelial function in Behçet's disease.HLA in Portuguese systemic lupus erythematosus patients and their relation to clinical features.CCR5-Delta32: implications in SLE development.HLA and age of onset in myasthenia gravisVitamin D supplementation effects on FoxP3 expression in T cells and FoxP3+/IL-17A ratio and clinical course in systemic lupus erythematosus patients: a study in a Portuguese cohortAssociation between vitamin D receptor (VDR) gene polymorphisms and systemic lupus erythematosus in Portuguese patientsThe role of KIR2DS1 in multiple sclerosis - KIR in Portuguese MS patientsHFE gene polymorphisms and severity in Portuguese patients with multiple sclerosisNew insights of HLA class I association to Behçet’s disease in Portuguese patientsThe role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis populationAwareness and screening attitudes of Portuguese dermatologists on cardiovascular risk factors in psoriatic patientsPsoriasis pharmacogenetics: HLA-Cw*0602 as a marker of therapeutic response to ustekinumabCirculating microRNAs as potential biomarkers for genetic generalized epilepsies: a three microRNA panelApolipoprotein E isoforms and susceptibility to genetic generalized epilepsies
P50
Q36271927-147816D2-B1A6-49A1-B9D4-F8E30C0CB329Q39162843-A07F208F-AA5B-460B-B51C-B32C38172801Q40165044-F825E26E-0D91-452C-AFF3-4744BC93A7FDQ40915108-3ACF576D-8556-4C84-8476-E754A5E2EB0BQ40967590-A8614585-E11F-4AB7-ABEF-BA4A66F591C2Q43275862-ACEA6FD3-CE0D-4ED0-ADA8-CB98C99A452AQ47687523-EADE054A-1DF7-4E74-B860-B4504BABE845Q48181978-50E16D86-697D-4665-9B99-D053FA1C3586Q48824784-831C32C9-6E95-458A-B1B8-957ABFA374F2Q48939724-D022AE79-F224-4BFA-A052-EC6BD933352DQ49813869-364CD076-2C02-4893-B881-35B9CA60D6B1Q51040386-375E7F1B-356C-4420-9395-74001C899565Q54465103-DDCC448E-8D25-4EF4-A910-4F782F5F0225Q54688004-CA2C1870-76A0-423F-920F-FB0BE5A33C04Q57526155-7E67C8B0-45BB-4855-961D-4090B7A1F26CQ57526158-0B1036C8-336B-42B3-89C2-EC6F0E3D7B0AQ57526162-B96087AE-E2D1-4E4F-B16D-97EBF05C12B2Q57526190-858EF8DC-4037-418C-9C53-938F1418B828Q57526223-9153AE93-40B4-40A9-BC4C-46C7C8C439B1Q57526240-B4E56058-236A-4EAB-BDB9-90FB4B960845Q57526251-137B77F9-371C-4E0B-BB30-8ACB3564BEDFQ88611966-7EADBF64-8595-439C-AC3B-52132A46C988Q89771539-D7F574B8-8748-442A-9981-E3A08E283256Q91351885-1E514237-EF33-4222-B971-20D19986AF91Q92251506-BAD70D66-3BDF-4F15-BB05-A64223718746
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Andreia Bettencourt
@ast
Andreia Bettencourt
@en
Andreia Bettencourt
@es
Andreia Bettencourt
@nl
Andreia Bettencourt
@sl
type
label
Andreia Bettencourt
@ast
Andreia Bettencourt
@en
Andreia Bettencourt
@es
Andreia Bettencourt
@nl
Andreia Bettencourt
@sl
prefLabel
Andreia Bettencourt
@ast
Andreia Bettencourt
@en
Andreia Bettencourt
@es
Andreia Bettencourt
@nl
Andreia Bettencourt
@sl
P1053
O-6038-2014
P106
P1153
24780579700
P21
P31
P3829
P496
0000-0001-5511-5137
P569
2000-01-01T00:00:00Z